Tsurumi Manufacturing Co.,Ltd. (TYO:6351)

Elevation Oncology Balance Sheet

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	31,631	31,145	29,198	20,179	14,484	15,707
Short-Term Investments	900	1,405	2,160	1,454	1,701	1,308
Cash & Short-Term Investments	32,531	32,550	31,358	21,633	16,185	17,015
Cash Growth	-12.35%	3.80%	44.95%	33.66%	-4.88%	9.55%
Receivables	21,023	23,293	21,298	19,622	19,669	18,465
Inventory	20,241	20,299	16,503	17,499	13,129	10,491
Other Current Assets	2,748	5,515	3,874	3,122	3,957	3,039
Total Current Assets	76,543	81,657	73,033	61,876	52,940	49,010
Property, Plant & Equipment	27,744	27,901	21,305	17,584	15,868	14,415
Long-Term Investments	-	15,557	18,730	17,042	16,546	16,092
Goodwill	3,042	3,184	-	-	-	-
Other Intangible Assets	2,750	2,887	2,075	1,965	1,481	1,435
Long-Term Deferred Tax Assets	-	321	206	531	463	534
Other Long-Term Assets	16,136	2	2	2	1	1
Total Assets	126,215	131,509	115,351	99,000	87,299	81,487
Accounts Payable	7,574	8,478	6,272	6,727	7,168	6,519
Accrued Expenses	1,609	1,249	1,456	1,325	1,129	953
Short-Term Debt	-	6,700	-	-	-	-
Current Portion of Long-Term Debt	5,192	1,696	1,053	2	-	1,000
Current Income Taxes Payable	1,192	1,168	2,046	1,490	1,274	1,164
Other Current Liabilities	5,120	6,537	4,274	3,632	3,146	2,473
Total Current Liabilities	20,687	25,828	15,101	13,176	12,717	12,109
Long-Term Debt	7,160	7,283	8,893	7,101	2,100	1,800
Long-Term Deferred Tax Liabilities	-	973	677	129	123	159
Other Long-Term Liabilities	2,380	1,423	365	126	175	210
Total Liabilities	30,382	35,658	25,157	20,840	15,452	14,613
Common Stock	5,188	5,188	5,188	5,188	5,188	5,188
Additional Paid-In Capital	8,005	8,369	8,313	8,028	7,810	7,810
Retained Earnings	73,900	76,003	68,498	61,191	55,957	52,133
Treasury Stock	-2,195	-4,423	-2,991	-3,123	-2,321	-2,119
Comprehensive Income & Other	9,418	9,262	9,796	5,606	4,198	2,968
Total Common Equity	94,316	94,399	88,804	76,890	70,832	65,980
Minority Interest	1,517	1,452	1,390	1,270	1,015	894
Shareholders' Equity	95,833	95,851	90,194	78,160	71,847	66,874
Total Liabilities & Equity	126,215	131,509	115,351	99,000	87,299	81,487
Total Debt	12,352	15,679	9,946	7,103	2,100	2,800
Net Cash (Debt)	20,179	16,871	21,412	14,530	14,085	14,215
Net Cash Growth	-26.02%	-21.21%	47.36%	3.16%	-0.92%	5.84%
Net Cash Per Share	828.11	689.06	872.18	589.24	562.84	567.74
Filing Date Shares Outstanding	24.02	24.09	24.55	24.5	24.77	25.04
Total Common Shares Outstanding	24.02	24.24	24.65	24.51	24.93	25.04
Working Capital	55,856	55,829	57,932	48,700	40,223	36,901
Book Value Per Share	3925.92	3893.84	3603.08	3137.66	2841.73	2635.18
Tangible Book Value	88,524	88,328	86,729	74,925	69,351	64,545
Tangible Book Value Per Share	3684.83	3643.42	3518.89	3057.47	2782.31	2577.87

Source: S&P Global Market Intelligence. Standard template. Financial Sources.